This company listing is no longer active
GDBY Stock Overview
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Goodbody Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0025 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | -1.23 |
| 1 Month Change | -84.62% |
| 3 Month Change | -90.00% |
| 1 Year Change | -98.98% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| GDBY | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -16.7% | 3.1% | 1.2% |
| 1Y | -99.0% | -3.1% | -0.3% |
Return vs Industry: GDBY underperformed the UK Pharmaceuticals industry which returned -2.7% over the past year.
Return vs Market: GDBY underperformed the UK Market which returned -1.2% over the past year.
Price Volatility
| GDBY volatility | |
|---|---|
| GDBY Average Weekly Movement | 20.2% |
| Pharmaceuticals Industry Average Movement | 8.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GDBY's share price has been volatile over the past 3 months.
Volatility Over Time: GDBY's weekly volatility has increased from 13% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | George Thomas | www.goodbodyhealth.com |
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom. The company also operates as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It has interests in COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.
Goodbody Health Limited Fundamentals Summary
| GDBY fundamental statistics | |
|---|---|
| Market cap | UK£64.33k |
| Earnings (TTM) | -UK£3.72m |
| Revenue (TTM) | UK£16.47m |
0.0x
P/S Ratio0.0x
P/E RatioIs GDBY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GDBY income statement (TTM) | |
|---|---|
| Revenue | UK£16.47m |
| Cost of Revenue | UK£8.38m |
| Gross Profit | UK£8.09m |
| Other Expenses | UK£11.82m |
| Earnings | -UK£3.72m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.10 |
| Gross Margin | 49.13% |
| Net Profit Margin | -22.61% |
| Debt/Equity Ratio | 0% |
How did GDBY perform over the long term?
See historical performance and comparison